Curcumin analogues and uses thereof
CA 2482002 C · Owner: Shih, Charles C. Y. · Inventors: Lee, Kuo-Hsiung; Chang, Chawnshang; Itokawa, Hideji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same and , methods of use thereof. Such uses include but are not limited to, use as , antitumor agents particularly for the treatment of cancers such as colon skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to baldness, hirsutism, behavioral disorders acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 27, 2003 and granted July 17, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 27, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.